|
MYO10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.34080000225146E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.94270000039876E-07 |
| Normal-vs-Stage2 |
5.539200E-03 |
| Normal-vs-Stage3 |
1.69800000004994E-06 |
| Normal-vs-Stage4 |
5.19018161782014E-12 |
| Stage1-vs-Stage2 |
9.043200E-01 |
| Stage1-vs-Stage3 |
3.619800E-01 |
| Stage1-vs-Stage4 |
3.67580000000256E-05 |
| Stage2-vs-Stage3 |
3.976600E-01 |
| Stage2-vs-Stage4 |
2.843600E-02 |
| Stage3-vs-Stage4 |
6.198400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.9173999962E-08 |
| Normal-vs-AfricanAmerican |
8.28890000000859E-05 |
| Normal-vs-Asian |
2.03930000000074E-05 |
| Caucasian-vs-AfricanAmerican |
9.785400E-01 |
| Caucasian-vs-Asian |
1.900800E-01 |
| AfricanAmerican-vs-Asian |
4.771800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29370000268025E-08 |
| Normal-vs-Female |
8.243000E-04 |
| Male-vs-Female |
2.019000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.295150E-03 |
| Normal-vs-Extreme_Weight |
3.3487999995252E-07 |
| Normal-vs-Obese |
5.80889999999279E-05 |
| Normal-vs-Extreme_Obese |
1.194960E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.564000E-01 |
| Normal_Weight-vs-Obese |
7.711800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.555600E-01 |
| Extreme_Weight-vs-Obese |
3.696000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.818000E-01 |
| Obese-vs-Extreme_Obese |
9.287600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.380500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.71670000051571E-07 |
| Normal-vs-Age(61-80Yrs) |
4.59260000029715E-07 |
| Normal-vs-Age(81-100Yrs) |
1.53560000049069E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.809800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.143200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.837600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.843000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.123700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.278000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8979000004915E-07 |
| Normal-VS-Type2 PRCC |
2.23759999995465E-06 |
| Normal-VS-KIRP CIMP |
2.402400E-03 |
| Normal-VS-Unclassified PRCC |
3.39949999994538E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.841800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.910400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.034400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.318800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.838600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.469800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35059741168675E-11 |
| Normal-vs-N1 |
1.90960000001628E-06 |
| Normal-vs-N2 |
6.161600E-03 |
| N0-vs-N1 |
4.891000E-01 |
| N0-vs-N2 |
7.374200E-01 |
| N1-vs-N2 |
9.828400E-01 |
|
|
